Steerable Laser Interstitial Thermotherapy (SLIT) Robot for Brain Tumor Therapy
用于脑肿瘤治疗的可操纵激光间质热疗 (SLIT) 机器人
基本信息
- 批准号:10572533
- 负责人:
- 金额:$ 23.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-01 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:AblationAdjuvantAgarAirAlgorithmsAnimal ModelAnimalsApplications GrantsBrainBrain NeoplasmsComputer softwareCranial IrradiationCustomDevelopmentDevicesDiagnosisEnsureEvaluationFDA approvedFamily suidaeFiberFutureGadoliniumGlioblastomaGoalsIn VitroInduced HyperthermiaIntelligenceLasersLesionLocationMagnetic ResonanceMagnetic Resonance ImagingMalignant NeoplasmsMechanicsModalityModelingMorphologyMotionNeoplasm MetastasisNeurosurgical ProceduresOperative Surgical ProceduresOrganOutcomePatientsPeripheralPharmaceutical PreparationsPrimary Brain NeoplasmsProceduresPrognosisProtocols documentationRadiationRadiation necrosisRecurrenceRepeat SurgeryResearch PersonnelRobotRoboticsSafetyShapesSiteStructureSystemTechniquesTemperature SenseTendon structureTestingThermometryTissuesTrephine holeTumor TissueUnited States National Institutes of HealthWorkclinically relevantdesigneffective therapyflexibilitygraphical user interfaceimprovedin vivointerstitialkinematicsminimally invasivemultidisciplinaryneuropathologyneurosurgerynovelphantom modelporcine modelpre-clinicalpreventremote monitoringrobot controlskillssoftware developmenttechnology developmenttumortumor ablation
项目摘要
Project Summary/Abstract
Glioblastoma (GBM) is one of the most prevalent and challenging cancers to cure. Each year, nearly 12,000 new
cases of GBM are diagnosed in the US, with the overall median survival being only 12 to 18 months. GBM rarely
metastasizes to other organs; however, there is no effective treatment for GBM tumors. Standard therapies with
surgery combined with adjuvant radiation and FDA-approved drugs can add a few months to median survival
but cannot prevent the recurrence of GBM. For recurrent GBM (rGBM), prognosis is even more dismal. Repeated
surgery is often not recommended since patients have already gone through it during the treatment of initial
GBM, and the efficacy of other treatment options is very limited. Laser interstitial thermotherapy (LITT) is an
emerging technique for minimally invasive treatment of rGBM. By introducing a slender laser probe into a brain
tumor, LITT can ablate the tumor tissue percutaneously using laser radiation. However, existing LITT devices
which often set the tip of a laser probe at the core of the tumor are inadequate to achieve conformal ablation (i.e.,
ablation with the maximum tumor coverage and minimum collateral damage), especially when tumors are large,
irregularly shaped, or multifocal. Hence, to achieve conformal ablation and improve the efficacy of LITT, we
propose a novel robot to deliver thermal radiation at multiple locations inside a brain tumor. We will develop a
novel steerable laser interstitial thermotherapy (SLIT) robot with a slender footprint and a custom-
designed flexible laser ablation probe. We will introduce SLIT to the peripheral of a brain tumor through a small
burr hole, manipulate SLIT around critical structures, and perform ablation at targets that are planned by
clinicians under the guidance of magnetic resonance imaging (MRI). All aspects of new procedure will be
remotely monitored and controlled by clinicians using intra-operative MRI and thermometry (MRT) to ensure
precision and safety. In this project, we will 1) Design and develop an MR-compatible steerable robot with a
flexible ablation probe, 2) Develop software that enables planning and control of multi-site tumor ablation, and
3) Evaluate the safety and functionality of SLIT using clinically relevant models. We have formed a
multidisciplinary team with expertise in minimally invasive surgical robots, biomedical fiber lasers,
neurosurgery, neurosurgical devices, neuropathology, advanced MR imaging, animal models, and
neuroradiology to successfully conduct the proposed studies. LITT for rGBM therapy will serve as a model for
technology development, while the outcome will generate a transformative platform with applications to many
neurosurgical procedures that require dexterous minimally invasive access to brain lesions.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jun Sheng其他文献
Jun Sheng的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Metachronous synergistic effects of preoperative viral therapy and postoperative adjuvant immunotherapy via long-term antitumor immunity
术前病毒治疗和术后辅助免疫治疗通过长期抗肿瘤免疫产生异时协同效应
- 批准号:
23K08213 - 财政年份:2023
- 资助金额:
$ 23.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improving the therapeutic immunity of cancer vaccine with multi-adjuvant polymeric nanoparticles
多佐剂聚合物纳米粒子提高癌症疫苗的治疗免疫力
- 批准号:
2881726 - 财政年份:2023
- 资助金额:
$ 23.24万 - 项目类别:
Studentship
Countering sympathetic vasoconstriction during skeletal muscle exercise as an adjuvant therapy for DMD
骨骼肌运动期间对抗交感血管收缩作为 DMD 的辅助治疗
- 批准号:
10735090 - 财政年份:2023
- 资助金额:
$ 23.24万 - 项目类别:
Evaluation of the Sensitivity to Endocrine Therapy (SET ER/PR) Assay to predict benefit from extended duration of adjuvant endocrine therapy in the NSABP B-42 trial
NSABP B-42 试验中内分泌治疗敏感性 (SET ER/PR) 测定的评估,用于预测延长辅助内分泌治疗持续时间的益处
- 批准号:
10722146 - 财政年份:2023
- 资助金额:
$ 23.24万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 23.24万 - 项目类别:
DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINES
流感疫苗类 AS01 合成佐剂系统 SAS 的开发
- 批准号:
10935776 - 财政年份:2023
- 资助金额:
$ 23.24万 - 项目类别:
DEVELOPMENT OF SMALL-MOLECULE DUAL ADJUVANT SYSTEM FOR INFLUENZA VIRUS VACCINE
流感病毒疫苗小分子双佐剂体系的研制
- 批准号:
10935796 - 财政年份:2023
- 资助金额:
$ 23.24万 - 项目类别:
A GLYCOLIPID ADJUVANT 7DW8-5 FOR MALARIA VACCINES
用于疟疾疫苗的糖脂佐剂 7DW8-5
- 批准号:
10935775 - 财政年份:2023
- 资助金额:
$ 23.24万 - 项目类别:
Adjuvant Photodynamic Therapy to Reduce Bacterial Bioburden in High-Energy Contaminated Open Fractures
辅助光动力疗法可减少高能污染开放性骨折中的细菌生物负载
- 批准号:
10735964 - 财政年份:2023
- 资助金额:
$ 23.24万 - 项目类别:
Adjuvant strategies for universal and multiseasonal influenza vaccine candidates in the context of pre-existing immunity
在已有免疫力的情况下通用和多季节流感候选疫苗的辅助策略
- 批准号:
10649041 - 财政年份:2023
- 资助金额:
$ 23.24万 - 项目类别: